These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22555174)

  • 1. Ciliated adenocarcinomas of the lung: a tumor of non-terminal respiratory unit origin.
    Park WY; Kim MH; Shin DH; Lee JH; Choi KU; Kim JY; Park DY; Lee CH; Sol MY
    Mod Pathol; 2012 Sep; 25(9):1265-74. PubMed ID: 22555174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucinous bronchioloalveolar carcinoma with K-ras mutation arising in type 1 congenital cystic adenomatoid malformation: a case report with review of the literature.
    Ishida M; Igarashi T; Teramoto K; Hanaoka J; Iwai M; Yoshida K; Kagotani A; Tezuka N; Okabe H
    Int J Clin Exp Pathol; 2013; 6(11):2597-602. PubMed ID: 24228126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between EGFR and KRAS mutations and prognosis in Chinese patients with non-small cell lung cancer: a mutation analysis with real-time polymerase chain reaction using scorpion amplification refractory mutation system].
    Gao J; Chen JQ; Zhang L; Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):652-6. PubMed ID: 23302304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lung non-terminal respiratory unit type adenocarcinoma: a clinicopathologic study].
    Liu B; Wu N; Shen Q; Shi SS; Zhang SS; Ru Y; Rao Q; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):603-608. PubMed ID: 30107665
    [No Abstract]   [Full Text] [Related]  

  • 5. EGFR mutation is specific for terminal respiratory unit type adenocarcinoma.
    Yatabe Y; Kosaka T; Takahashi T; Mitsudomi T
    Am J Surg Pathol; 2005 May; 29(5):633-9. PubMed ID: 15832087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-terminal respiratory unit type lung adenocarcinoma has three distinct subtypes and is associated with poor prognosis.
    Sumiyoshi S; Yoshizawa A; Sonobe M; Kobayashi M; Sato M; Fujimoto M; Tsuruyama T; Date H; Haga H
    Lung Cancer; 2014 Jun; 84(3):281-8. PubMed ID: 24725383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.
    Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT
    J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung.
    Soh J; Toyooka S; Ichihara S; Asano H; Kobayashi N; Suehisa H; Otani H; Yamamoto H; Ichimura K; Kiura K; Gazdar AF; Date H
    J Thorac Oncol; 2008 Apr; 3(4):340-7. PubMed ID: 18379350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are there imaging characteristics associated with epidermal growth factor receptor and KRAS mutations in patients with adenocarcinoma of the lung with bronchioloalveolar features?
    Glynn C; Zakowski MF; Ginsberg MS
    J Thorac Oncol; 2010 Mar; 5(3):344-8. PubMed ID: 20087229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma patients.
    Tanaka A; Sueoka-Aragane N; Nakamura T; Takeda Y; Mitsuoka M; Yamasaki F; Hayashi S; Sueoka E; Kimura S
    Lung Cancer; 2012 Jan; 75(1):89-94. PubMed ID: 21733594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchioloalveolar neoplasia.
    Kitamura H; Okudela K
    Int J Clin Exp Pathol; 2010 Nov; 4(1):97-9. PubMed ID: 21228931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease.
    Mackinnon AC; Tretiakova M; Henderson L; Mehta RG; Yan BC; Joseph L; Krausz T; Husain AN; Reid ME; Salgia R
    J Clin Pathol; 2011 Jan; 64(1):16-24. PubMed ID: 21045234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers.
    Sholl LM; Yeap BY; Iafrate AJ; Holmes-Tisch AJ; Chou YP; Wu MT; Goan YG; Su L; Benedettini E; Yu J; Loda M; Jänne PA; Christiani DC; Chirieac LR
    Cancer Res; 2009 Nov; 69(21):8341-8. PubMed ID: 19826035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
    Miller VA; Riely GJ; Zakowski MF; Li AR; Patel JD; Heelan RT; Kris MG; Sandler AB; Carbone DP; Tsao A; Herbst RS; Heller G; Ladanyi M; Pao W; Johnson DH
    J Clin Oncol; 2008 Mar; 26(9):1472-8. PubMed ID: 18349398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor gene mutations in atypical adenomatous hyperplasias of the lung.
    Sakuma Y; Matsukuma S; Yoshihara M; Nakamura Y; Nakayama H; Kameda Y; Tsuchiya E; Miyagi Y
    Mod Pathol; 2007 Sep; 20(9):967-73. PubMed ID: 17618248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma.
    Rekhtman N; Ang DC; Riely GJ; Ladanyi M; Moreira AL
    Mod Pathol; 2013 Oct; 26(10):1307-19. PubMed ID: 23619604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma.
    Xu X; Rock JR; Lu Y; Futtner C; Schwab B; Guinney J; Hogan BL; Onaitis MW
    Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4910-5. PubMed ID: 22411819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS mutation-positive bronchial surface epithelium (BSE)-type lung adenocarcinoma with strong expression of TTF-1: a case providing a further insight as for the role of TTF-1 in the oncogenesis.
    Takanashi Y; Tajima S; Hayakawa T; Neyatani H; Funai K
    Int J Clin Exp Pathol; 2015; 8(11):15338-43. PubMed ID: 26823891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of EGFR and KRAS mutations in Japanese patients with lung adenocarcinoma with features of the mucinous subtype of bronchioloalveolar carcinoma.
    Hata A; Katakami N; Fujita S; Kaji R; Imai Y; Takahashi Y; Nishimura T; Tomii K; Ishihara K
    J Thorac Oncol; 2010 Aug; 5(8):1197-200. PubMed ID: 20661086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary pleomorphic carcinoma: a clinicopathological study including EGFR mutation analysis.
    Kaira K; Horie Y; Ayabe E; Murakami H; Takahashi T; Tsuya A; Nakamura Y; Naito T; Endo M; Kondo H; Nakajima T; Yamamoto N
    J Thorac Oncol; 2010 Apr; 5(4):460-5. PubMed ID: 20107421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.